1. Single-Cell Omics: Strategies Towards Theranostic Biomarker Discovery Along the Continuum of Premalignant to Invasive Disease in Oncology
    Sinem Nalbantoglu et al, 2019, Single-Cell Omics CrossRef
  2. PROTEÍNAS MIR-203A-3P E MMP-2 SÃO ALTAMENTE EXPRESSAS EM CÉLULAS TUMORAIS CIRCULANTES DE PACIENTES COM CARCINOMA PANCREÁTICO
    José Gabriel Rodríguez TARAZONA et al, 2021, ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) CrossRef
  3. Improvement in immune dysfunction after FOLFOX chemotherapy for Stage III colon cancer is associated with improved minimal residual disease prognostic subtype and outcome
    Nigel P. Murray et al, 2021, Colorectal Disease CrossRef
  4. Secondary Circulating Prostate Cells Predict Biochemical Failure in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease
    Nigel P. Murray et al, 2013, The Scientific World Journal CrossRef
  5. TGF Beta1 Expression Correlates with Survival and Tumor Aggressiveness of Prostate Cancer
    Chun-Te Wu et al, 2015, Annals of Surgical Oncology CrossRef
  6. Matrix Metalloproteinases: A challenging paradigm of cancer management
    Ali Alaseem et al, 2019, Seminars in Cancer Biology CrossRef
  7. The Advantage of Antibody Cocktails for Targeted Alpha Therapy Depends on Specific Activity
    Jordan B. Pasternack et al, 2014, Journal of Nuclear Medicine CrossRef
  8. Breast Cancer Stem Cells: Current Advances and Clinical Implications
    Ming Luo et al, 2015, Mammary Stem Cells CrossRef
  9. Synergistic action of image-guided radiotherapy and androgen deprivation therapy
    Jennifer A. Locke et al, 2015, Nature Reviews Urology CrossRef
  10. Functional analysis of single cells identifies a rare subset of circulating tumor cells with malignant traits
    Xiaosai Yao et al, 2014, Integrative Biology CrossRef
  11. The significance of circulating tumor cells in prostate cancer patients undergoing adjuvant or salvage radiation therapy
    L E Lowes et al, 2015, Prostate Cancer and Prostatic Diseases CrossRef
  12. Minimal residual disease in prostate cancer patients after primary treatment: theoretical considerations, evidence and possible use in clinical management
    Nigel P. Murray, 2018, Biological Research CrossRef
  13. Testosterone Deficiency, Supplementation, and Prostate Cancer: Maintaining a Balanced Perspective
    Landon W. Trost et al, 2013, The Journal of Sexual Medicine CrossRef
  14. Blood-Derived Biomarkers of Diagnosis, Prognosis and Therapy Response in Prostate Cancer Patients
    Katalin Balázs et al, 2021, Journal of Personalized Medicine CrossRef
  15. Breast cancer stem cells and their role in tumor microenvironment
    Manzoor Ahmad Mir et al, 2022, Role of Tumor Microenvironment in Breast Cancer and Targeted Therapies CrossRef
  16. Cancer Stem Cells and Circulating Tumor Cells: Molecular Markers, Isolation Techniques, and Clinical Implications
    Ebrahim Azizi et al, 2016, Circulating Tumor Cells CrossRef
  17. Resveratrol Suppresses Prostate Cancer Epithelial Cell Scatter/Invasion by Targeting Inhibition of Hepatocyte Growth Factor (HGF) Secretion by Prostate Stromal Cells and Upregulation of E-cadherin by Prostate Cancer Epithelial Cells
    Tze-chen Hsieh et al, 2020, International Journal of Molecular Sciences CrossRef
  18. Comparison between Use of PSA Kinetics and Bone Marrow Micrometastasis to Define Local or Systemic Relapse in Men with Biochemical Failure after Radical Prostatectomy for Prostate Cancer
    Nigel P Murray et al, 2016, Asian Pacific Journal of Cancer Prevention CrossRef